HAO1
Basic information
Region (hg38): 20:7882985-7940458
Previous symbols: [ "GOX1" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the HAO1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 30 | 31 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 30 | 1 | 0 |
Variants in HAO1
This is a list of pathogenic ClinVar variants found in the HAO1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
20-7883607-C-T | not specified | Uncertain significance (Mar 29, 2023) | ||
20-7885529-G-A | not specified | Uncertain significance (Nov 13, 2024) | ||
20-7885541-C-A | not specified | Uncertain significance (May 08, 2024) | ||
20-7885726-C-T | not specified | Likely benign (Sep 14, 2022) | ||
20-7885795-G-A | not specified | Uncertain significance (Sep 01, 2021) | ||
20-7885852-G-A | not specified | Uncertain significance (Jun 03, 2022) | ||
20-7885861-C-T | not specified | Uncertain significance (Oct 12, 2021) | ||
20-7885865-C-G | Uncertain significance (Jul 17, 2020) | |||
20-7888809-T-C | Nephrolithiasis, calcium oxalate | association (Mar 01, 2014) | ||
20-7890075-C-T | Nephrolithiasis, calcium oxalate | association (Mar 01, 2014) | ||
20-7895150-C-T | not specified | Uncertain significance (Jul 26, 2024) | ||
20-7895158-C-T | not specified | Uncertain significance (Jan 03, 2024) | ||
20-7895173-G-A | not specified | Uncertain significance (Aug 02, 2021) | ||
20-7895190-C-A | not specified | Uncertain significance (Sep 05, 2024) | ||
20-7895208-C-G | not specified | Uncertain significance (Jul 30, 2024) | ||
20-7904537-C-G | Nephrolithiasis, calcium oxalate | association (Mar 01, 2014) | ||
20-7906224-G-C | not specified | Uncertain significance (May 24, 2024) | ||
20-7906244-T-C | not specified | Uncertain significance (Jul 09, 2021) | ||
20-7906286-C-G | not specified | Uncertain significance (Aug 26, 2024) | ||
20-7906322-T-A | not specified | Uncertain significance (Nov 08, 2021) | ||
20-7912993-A-G | Nephrolithiasis, calcium oxalate | association (Mar 01, 2014) | ||
20-7914194-C-T | not specified | Uncertain significance (Nov 30, 2021) | ||
20-7914210-G-A | not specified | Uncertain significance (Sep 16, 2021) | ||
20-7914231-C-G | not specified | Uncertain significance (May 31, 2022) | ||
20-7914299-C-T | not specified | Uncertain significance (Oct 03, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
HAO1 | protein_coding | protein_coding | ENST00000378789 | 8 | 57494 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.46e-7 | 0.623 | 125694 | 0 | 46 | 125740 | 0.000183 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.497 | 239 | 218 | 1.09 | 0.0000123 | 2387 |
Missense in Polyphen | 111 | 95.431 | 1.1631 | 990 | ||
Synonymous | 0.182 | 81 | 83.1 | 0.975 | 0.00000477 | 749 |
Loss of Function | 1.10 | 13 | 18.0 | 0.720 | 9.14e-7 | 213 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000473 | 0.000471 |
Ashkenazi Jewish | 0.000298 | 0.000298 |
East Asian | 0.000329 | 0.000326 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000150 | 0.000149 |
Middle Eastern | 0.000329 | 0.000326 |
South Asian | 0.000131 | 0.000131 |
Other | 0.000164 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Has 2-hydroxyacid oxidase activity. Most active on the 2-carbon substrate glycolate, but is also active on 2-hydroxy fatty acids, with high activity towards 2-hydroxy palmitate and 2- hydroxy octanoate. {ECO:0000269|PubMed:18215067}.;
- Pathway
- Peroxisome - Homo sapiens (human);Glyoxylate and dicarboxylate metabolism - Homo sapiens (human);Metabolism of proteins;Metabolism of amino acids and derivatives;Metabolism;Peroxisomal protein import;Glyoxylate metabolism and glycine degradation;Glycine, serine, alanine and threonine metabolism
(Consensus)
Recessive Scores
- pRec
- 0.302
Intolerance Scores
- loftool
- 0.818
- rvis_EVS
- 0.31
- rvis_percentile_EVS
- 72.38
Haploinsufficiency Scores
- pHI
- 0.156
- hipred
- N
- hipred_score
- 0.350
- ghis
- 0.405
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.950
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Hao1
- Phenotype
Gene ontology
- Biological process
- fatty acid alpha-oxidation;protein targeting to peroxisome;response to oxidative stress;cellular nitrogen compound metabolic process;glycolate catabolic process
- Cellular component
- peroxisome;peroxisomal matrix;cytosol
- Molecular function
- (S)-2-hydroxy-acid oxidase activity;signaling receptor binding;glycolate oxidase activity;FMN binding;glyoxylate oxidase activity;very-long-chain-(S)-2-hydroxy-acid oxidase activity;long-chain-(S)-2-hydroxy-long-chain-acid oxidase activity;medium-chain-(S)-2-hydroxy-acid oxidase activity